NMSG8 - Aredia Myelom
Official title: The effect of i.v. bisphosphonate on health-related quality of life and skeletal morbidity for newly diagnosed treatment demanding multiple myeloma. A prospective randomised double blinded dose-effective study with cost-utility analysisTrial start year: 2001
Trial website
No website available
Design paper
No design paper published
![Result paper](http://ctu.dk/wp-content/uploads/2020/11/NSMG8_main2010_remade-01.png)
Result paper
2010
Eff ect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial
Download full paper